The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Development of brain metastases in patients with metastatic melanoma treated with ipilimumab plus temozolomide.
Jennifer Wang
No relevant relationships to disclose
Sapna Pradyuman Patel
No relevant relationships to disclose
Wen-Jen Hwu
No relevant relationships to disclose
Kevin B. Kim
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Nicholas E. Papadopoulos
No relevant relationships to disclose
Patrick Hwu
No relevant relationships to disclose
Laszlo George Radvanyi
No relevant relationships to disclose
Sandy Mahoney
No relevant relationships to disclose
Tawania L Deburr
No relevant relationships to disclose
Roland Bassett
No relevant relationships to disclose
Agop Y. Bedikian
Research Funding - Bristol-Myers Squibb